Balyasny Asset Management LLC Orchard Therapeutics PLC Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.45 - $0.69 $15,172 - $23,264
33,717 New
33,717 $17,000
Q3 2019

Nov 14, 2019
SELL
$11.88 - $16.72 $2.72 Million - $3.83 Million
-229,093 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$13.2 - $20.63 $3.02 Million - $4.73 Million
229,093 New
229,093 $3.21 Million

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email